Ausgabe 4/2005
Inhalt (14 Artikel)
Recent developments in the management of invasive fungal infections in patients with hematological malignancies
Meinolf Karthaus, Oliver A. Cornely
Long-term results of dose density therapy in patients with aggressive lymphoma
Michael A. Fridrik, Hubert Hausmaninger, Werner Linkesch, Richard Greil, Otto Krieger, Christian Baldinger, Joerg Klocker, Joerg Pont, Willhelm Oberaigner
Treatment results of tonsillar lymphoma: a 10-year experience
Mohammad Mohammadianpanah, Shapour Omidvai, Ahmad Mosalei, Niloofar Ahmadloo
A phase I/II study of oral etoposide and idarubicin in elderly patients with high-risk acute myeloid leukemia unable to undergo intensive chemotherapy
Michael Fiegl, Thomas Büchner, Wolfgang Hiddemann, Jan Braess
Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura
Pavan S. Reddy, Delva Deauna-Limayo, James D. Cook, Siddhartha S. Ganguly, Carol Blecke, David C. Bodensteiner, Barry S. Skikne, Mervin A. Sahud
Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis
Christian Scholz, Inko Nimmrich, Matthias Burger, Evelyne Becker, Bernd Dörken, Wolf-Dieter Ludwig, Sabine Maier
Pericentric chromosome 8 inversion associated with the 5′RUNX1/3′CBFA2T1 gene in acute myeloid leukemia cases
L. Anelli, F. Albano, A. Zagaria, A. Liso, A. Cuneo, M. Mancini, V. Liso, M. Rocchi, G. Specchia
Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information
Ulrike Bacher, Torsten Haferlach, Wolfgang Kern, Wolfgang Hiddemann, Susanne Schnittger, Claudia Schoch
Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter
K. Jaeger, S. Zenz, B. Jüttner, H. Ruschulte, E. Kuse, J. Heine, S. Piepenbrock, A. Ganser, M. Karthaus
Striking complete remission after interferon-α for secondary recurrent non-Hodgkin’s lymphoma but rare interferon-induced side effects
Barbara Deschler, Martin Reincke, Thorsten A. Bley, Ingo Brink, Monika Engelhardt
Refractory post-pancreatitis thrombotic thrombocytopenic purpura: response to rituximab
Jimmy Ruiz, Prasad R. Koduri, Manuel Valdivieso, Prabodh C. Shah
Successful treatment of lymphoma with fludarabine combined with rituximab after immune thrombocytopenia induced by fludarabine
Yutaka Tsutsumi, Hiroe Kanamori, Hiina Minami, Mio Musashi, Arata Fukushima, Nobuyuki Ehira, Hiroaki Yamato, Shinji Obara, Nobutaka Ogura, Junji Tanaka, Masahiro Asaka, Masahiro Imamura, Nobuo Masauzi
Erythroblastic synartesis in a patient initially diagnosed with myelodysplastic syndrome
U. Bacher, G. Lenz, T. Haferlach, H. Loeffler, N. Moosmann, W. Hiddemann, H. Ostermann
Spontaneous complete and sustained remission of a rearrangement CBP (16p13)-positive disseminated congenital myelosarcoma
Carl Friedrich Classen, Wolfgang Behnisch, Dirk Reinhardt, Margit Koenig, Peter Möller, Klaus-Michael Debatin